William Pickering
Stock Analyst at Bernstein
(1.64)
# 3,140
Out of 4,732 analysts
23
Total ratings
40%
Success rate
-1.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $246.27 | +25.88% | 2 | Jan 7, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $1,110 → $1,070 | $681.58 | +56.99% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $19.56 | +22.70% | 2 | Nov 29, 2024 | |
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $37.59 | +75.58% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $61.53 | +46.27% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $31.43 | - | 2 | Jun 14, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $422.00 | - | 5 | Feb 2, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $9.50 | +468.42% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $23.44 | +57.85% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $1.82 | +229.67% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $40.53 | +8.56% | 1 | Mar 21, 2023 |
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $246.27
Upside: +25.88%
Regeneron Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $1,110 → $1,070
Current: $681.58
Upside: +56.99%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $19.56
Upside: +22.70%
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $37.59
Upside: +75.58%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $61.53
Upside: +46.27%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $31.43
Upside: -
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $422.00
Upside: -
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $9.50
Upside: +468.42%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $23.44
Upside: +57.85%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.82
Upside: +229.67%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $40.53
Upside: +8.56%